Key populations brief
Accessed November 2017
Comment donner du poids à vos messages sur la tuberculose
WHO/HTM/STB/2009.57
Rapport de plaidoyer Mars 2011
303100 03/2011 E 1,000
the tuberculosis survival project … “…ta guérison, ta vie”
Accessed November 2017
Overcoming Barriers to TB Control
Training Curriculum
August 2011
Rapport sur les populations clès
Accessed November 2017
Key populations brief
Accessed 2017
Rapport sur les populations clés.
Rapport sur les populations clés.
END TB
Second Meeting of th WHO Global Coordination Mechanism (GCM/NCD) Working Group on the inclusion of NCDs in other programmatic areas.
Accessded December 2017
TB policies in 29 Countries
A survey of prevention, testing and treatment policies and practices
Towards a world free of tuberculosis
The new, all oral, 20-month MDR-TB regimens range from US $1,600* (using bedaquiline and linezolid for 6 months and levofloxacin as the fluoroquinolone) to US $2,100* (using linezolid for 12 months and moxifloxacin as the fluoroquinolone.
Rapport sur les populations clès
Accessed November 2017
Documentos Téchnico Normativos
Technical information note. Digital Adherence Technologies (DATs) such as the smart medication container
kit can help to support people affected by TB with their treatment in a modern
and ef-fective way. These technologies are able to deliver reminders and may
help em-power TB affected individual...s and their families to take their daily
medication at a time and place that suits them best. They also generate a
digital record of medication intake.
more